Boehringer Ingelheim’s CHC moves to Sanofi
Consumers all over the world trust the Boehringer Ingelheim Consumer Health Care (CHC) business to bring relief from everyday ailments. These brands are directly available without the need for a prescription from a doctor.
Sanofi and Boehringer Ingelheim exchanged the CHC business from Boehringer Ingelheim with Sanofi’s Animal Health Business (Merial) on January 1st 2017. This is an important event in the history of both companies in order to reach a more competitive position in the key growth segments of the industry.
Further information is available via the following links:
We would like to thank all of you for the trust in our products. We are excited about this opportunity and strongly convinced to bring more value and innovation to customers globally.